PharmaCare Publications

• Pharmaceutical Services Act
• Provider Regulation
• Drug Plans Regulation
  • List of Related Services
  • Schedules 1 and 2
• Drug Price Regulation
  • Drug Price Regulation – Schedule (PDF, 1.0MB): list of drugs to which Section 5(2) (Low cost alternative categories established before April 1, 2013) of the Regulation applies
  • Drug Price Regulation – Schedule Amendment (PDF, 1.2MB)
• Information Management Regulation

• BC Smoking Cessation Program: Evaluation of the Nicotine Replacement Component (PDF, 278KB)
• ​Attention Deficit Hyperactivity Disorder (ADHD) Drug Therapy Review Reports
• Alzheimer's Drug Therapy Review Reports for the Drug Benefit Council (DBC)
• Evaluation reports of the Collaboration for Outcomes Research and Evaluation (CORE) at the Faculty of Pharmaceutical Sciences, University of British Columbia (www.core.ubc.ca):
  • An Overview of Pharmacy Adaptation Services in British Columbia (PDF, 423KB)
  • Pharmacy Adaptation in BC: The Physicians Perspective (PDF, 531KB)
• Report of the Pharmaceutical Task Force—April 2008 (PDF, 3.8MB)
• Activity Based Costing Study Report—January 2007 (PDF, 1.6MB)

• PharmaCare Trends 2019/20 (PDF, 714KB)
• PharmaCare Trends 2018/19 (PDF, 601KB)
• PharmaCare Trends 2017/18 (PDF, 581KB)
• PharmaCare Trends 2016/17 (PDF, 580KB)
• PharmaCare Trends 2015/16 (PDF, 591KB)
• PharmaCare Trends 2014/15 (PDF, 1.5MB)
• PharmaCare Trends 2013/14 (PDF, 2.8MB)
• PharmaCare Trends 2012/13 (PDF, 2.5MB)
• PharmaCare Trends 2011/12 (PDF, 2.5MB)
• PharmaCare Trends 2010/11 (PDF, 552KB)
• PharmaCare Trends 2009/10 (PDF, 773KB)
• PharmaCare Trends 2007/08 (PDF, 590KB))
• Pharmaceutical Services Division Annual Performance Report 2006 (PDF, 2.0MB)
• PharmaCare Annual Performance Report 2005 (PDF, 1.5MB)

The RDP was updated in April 2021. Find out about the RDP program and its history at Reference Drug Program.

• 2021 RDP Poster (PDF, 98KB)
• 2021 RDP Reference Sheet (PDF, 125KB)  – a close look at changes to Nitrates and NSAIDs categories

Decision Trees for Switching Drugs:

• Angiotensin Converting Enzyme Inhibitors (ACEIs) (PDF)
• Angiotensin Receptor Blockers (ARBs) (PDF)
• Dihydropyridine Calcium Channel Blockers (CCBs) (PDF)
• Histamine2 Receptor Blockers (H2 Blockers) (PDF)
• Proton Pump Inhibitors (PPIs) (PDF)
• Statins (PDF)

•  iOAT considerations (PDF)

• Downloadable Drug Data File
• Low Cost Alternative/Reference Drug Program Data Files
• PharmaNet Compliance Standards
• 2018/19 British Columbia Controlled Prescription Drug Atlas (PDF, 3.2 MB)